Holdam, Anne Sofie Krogh <br/><br/>
Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting.  [electronic resource] 

 -  Scandinavian journal of gastroenterology  2016 
 - 706-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1502-7708 
<br/><br/><label>Standard No.: </label>10.3109/00365521.2015.1136352  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents--therapeutic use<br/>Biological Therapy<br/>Case-Control Studies<br/>Female<br/>Follow-Up Studies<br/>Health Status Indicators<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab--therapeutic use<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Retrospective Studies<br/>Surveys and Questionnaires<br/>Treatment Outcome<br/>Young Adult